메조테라피 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Mesotherapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,843,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 9,994,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,638,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 이번에 세계의 메조테라피 시장에 관한 종합 보고서를 발표했습니다. 촉진요인·동향·기회·과제 등 중요한 시장 역학을 상세히 분석하고, 시장 구조에 관한 상세 인사이트를 제공하고 있습니다.

주요 인사이트

• 메조테라피 시장 규모(2024년) : 5억 1,361만 5,400달러
• 시장 예측 금액(2033년) : 15억 110만 달러
• 세계 시장 성장률(CAGR 2024-2033년) : 12.7%

메조테라피 시장 : 조사 범위

메조테라피는 비타민, 효소, 호르몬, 식물 추출물을 피부의 중배엽층에 미량 주입하여 피부의 젊어짐과 탄력을 되찾고 지방을 감소시키는 방법입니다. 이 최소침습적 미용 시술은 주로 피부 회춘, 체형 교정, 국소 지방 감소에 사용됩니다. 메조테라피 시장은 클리닉, 피부과, 성형외과 등을 대상으로 하며, 주사제 및 비침습적 기기를 포함한 다양한 치료 옵션과 제품을 제공합니다. 시장 성장의 원동력은 비수술적 미용 시술에 대한 수요 증가, 메조테라피의 장점에 대한 인식 증가, 주사 기술의 발전으로 인한 치료 결과 및 환자 만족도 향상입니다.

시장 성장의 촉진요인:

세계 메조테라피 시장은 외과적 수술 대신 비침습적 미용 시술에 대한 선호도 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 피부 노화, 국소 지방 축적 및 기타 미용상의 문제로 인해 남녀 모두 메조테라피 치료에 대한 수요가 증가하고 있습니다. 첨단 메조테라피 주사제 및 병용 요법 개발 등 주사 장비 및 제제의 기술적 발전은 시장 확대를 더욱 촉진하고 있습니다. 또한 가처분 소득 증가, 미용 서비스 접근성 확대, 소셜미디어 및 유명인 추천의 영향력이 시장 성장과 소비자 관심을 높이고 있습니다.

시장 성장 억제요인 :

유망한 성장 전망에도 불구하고, 메조테라피 시장은 안전성 우려, 규제 문제, 높은 치료 비용 등의 문제에 직면해 있습니다. 타박상, 부종, 알레르기 반응과 같은 부작용의 가능성은 잠재적 환자들의 발길을 돌리게 하는 위험요소가 될 수 있습니다. 메조테라피 제품 및 시술의 승인 및 표준화와 관련된 규제 장벽은 시장 진입 및 운영 비용에 영향을 미칩니다. 또한 메조테라피의 높은 치료 비용과 보험 적용이 되지 않는 경우, 특히 의료 예산이 한정된 신흥 국가에서 접근성과 시장 침투가 제한될 수 있습니다. 이러한 문제를 해결하기 위해 업계 이해관계자들은 안전 프로토콜을 강화하고, 규제 명확화를 옹호하며, 비용 효율적인 치료 옵션을 모색해야 합니다.

시장 기회 :

메조테라피 시장은 기술 혁신, 소비자 선호도의 진화, 적용 영역의 확대로 인해 큰 성장 기회를 제공합니다. 무침 메조테라피 시스템 및 개인 맞춤형 치료 프로토콜과 같은 첨단 기술의 통합은 치료 효과와 환자의 편안함을 향상시킵니다. 또한 예방적 미용 치료 증가와 모발 재생, 셀룰라이트 제거 등 기존 용도를 넘어서는 메조테라피의 용도가 확대되면서 시장 잠재력이 확대되고 있습니다. 전략적 파트너십, R&D 투자, 혁신적인 메조테라피 솔루션 도입은 새로운 기회를 활용하고 역동적인 메조테라피 전망에서 시장 리더십을 유지하는 데 있으며, 매우 중요합니다.

보고서가 답변하는 주요 질문

• 세계 메조테라피 시장의 성장을 가속하는 주요 요인은?
• 다양한 의료 환경에서 어떤 메조테라피 용도와 치료 유형이 채택을 촉진하고 있는가?
• 기술의 발전은 메조테라피 시장 경쟁 구도에 어떤 영향을 미치고 있는가?
• 메조테라피 시장에 기여하는 주요 기업은 어디이며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 메조테라피 시장의 새로운 동향과 전망은?

목차

제1장 개요

제2장 시장 개요

• 시장 범위 / 분류
• 시장의 정의 / 범위 / 제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신 / 개발 동향

제4장 주요 성공 요인

• 채택률 / 사용 상황 분석 - 주요 통계
• 밸류체인 분석
• 주요 규제 - 지역별
• 제품의 USP 분석
• 최근 제품 승인
• PESTEL 분석
• Porter의 산업 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 적응증별
  • 유통 채널별
  • 지역별
• 2023년 시장 시나리오

제7장 세계 시장의 수량(유닛) 분석

• 과거 시장 수량(유닛) 분석, 2019-2023년
• 현재 및 향후 시장 규모(유닛) 예측, 2024-2033년
  • 전년대비 성장 동향 분석

제8장 세계 시장 - 가격 분석

• 지역별 가격 분석 : 제품별
• 가격 내역
  • 제조업체 레벨의 가격결정
  • 유통업체 레벨의 가격결정
• 세계 평균 가격 분석 벤치마크
• 가격결정 전제조건

제9장 세계 시장 수요(금액 백만 달러) 분석

• 과거 시장 금액(백만 달러) 분석, 2019-2023년
• 현재 및 향후 시장 금액(백만 달러) 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제10장 세계 시장 분석 : 제품별

• 서론 / 주요 조사 결과
• 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 제품별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러)와 수량(유닛) 분석과 예측 : 제품별, 2024-2033년
  • 메조테라피 필러 키트
  • 메조테라피 솔루션 키트
  • 메조테라피 케미컬 필링
  • 안티에이징 마스크
  • 메조테라피 크림
  • 메조테라피 스프레이
• 시장의 매력 분석 : 제품별

제11장 세계 시장 분석 : 적응증별

• 서론 / 주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 적응증별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 적응증별, 2024-2033년
  • 안티에이징
  • 얼굴 회춘
  • 주름 치료
  • 스트레치 마크
  • 여드름과 흉터 치료
  • 지방 감소
  • 탈모증
  • 기타
• 시장의 매력 분석 : 적응증별

제12장 세계 시장 분석 : 유통 채널별

• 서론 / 주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 적응증별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 유통 채널별, 2024-2033년
  • 병원
  • 피부과 클리닉
  • 미용 클리닉
  • 온라인 판매
  • 기타
• 시장의 매력 분석 : 유통 채널별

제13장 세계 시장 분석 : 지역별

• 서론
• 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 지역별, 2019-2023년
• 현재 및 향후 시장 금액(백만 달러)과 수량(유닛) 분석과 예측 : 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장의 매력 분석 : 지역별

제14장 북미 시장 분석

제15장 라틴아메리카 시장 분석

제16장 유럽 시장 분석

제17장 동아시아 시장 분석

제18장 남아시아 시장 분석

제19장 오세아니아 시장

제20장 중동 및 아프리카(MEA) 시장 분석

제21장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 집중
• 시장 입지 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 상세 정보
  • Laboratoires FILORGA SA
  • INSTITUTE BCN
  • Mesoskinline
  • Koru Pharmaceuticals Co., Ltd.
  • Fusion Meso
  • TOSKANI COSMETICS
  • Dr. Korman Laboratories Ltd.
  • Ostar Beauty Sci-Tech Co Ltd.
  • Aemesso USA Corp
  • Perse Belle
  • Dermo Aroma
  • Pluryal
  • Messoessence
  • Novaderm
  • Dermaqual
  • Allergan
  • Maypharm

제23장 사용되는 전제 조건과 두자어

제24장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global mesotherapy market. The report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Mesotherapy Market Size (2024E): USD 513.6154 million
• Projected Market Value (2033F): USD 1501.1 million
• Global Market Growth Rate (CAGR 2024 to 2033): 12.7%

Mesotherapy Market - Report Scope:

Mesotherapy involves delivering a series of microinjections of vitamins, enzymes, hormones, and plant extracts into the mesoderm layer of the skin to rejuvenate and tighten skin, as well as to reduce fat. This minimally invasive cosmetic procedure is primarily used for skin rejuvenation, body contouring, and reducing localized fat deposits. The mesotherapy market caters to clinics, dermatology centers, and cosmetic surgery centers, offering a range of treatment options and products, including injectables and non-invasive devices. Market growth is driven by increasing demand for non-surgical cosmetic procedures, rising awareness about mesotherapy benefits, and advancements in injection technologies, enhancing treatment outcomes and patient satisfaction.

Market Growth Drivers:

The global mesotherapy market is propelled by several key factors, including a growing preference for non-invasive cosmetic procedures as an alternative to surgical interventions. The increasing incidence of skin aging, localized fat accumulation, and other aesthetic concerns among both men and women contributes to the demand for mesotherapy treatments. Technological advancements in injection devices and formulations, such as the development of advanced mesotherapy injectables and combination therapies, further drive market expansion. Additionally, rising disposable incomes, greater access to cosmetic services, and the influence of social media and celebrity endorsements boost market growth and consumer interest.

Market Restraints:

Despite promising growth prospects, the mesotherapy market faces challenges related to safety concerns, regulatory issues, and high treatment costs. Potential side effects, such as bruising, swelling, and allergic reactions, pose risks that may deter potential patients. Regulatory hurdles related to the approval and standardization of mesotherapy products and procedures impact market entry and operational costs. Moreover, the high cost of mesotherapy treatments and the lack of insurance coverage can limit accessibility and market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these issues requires industry stakeholders to enhance safety protocols, advocate for regulatory clarity, and explore cost-effective treatment options.

Market Opportunities:

The mesotherapy market presents significant growth opportunities driven by technological innovations, evolving consumer preferences, and expanding application areas. The integration of advanced technologies, such as needle-free mesotherapy systems and personalized treatment protocols, enhances treatment efficacy and patient comfort. Furthermore, the growing trend of preventive aesthetic treatments and the expansion of mesotherapy applications beyond traditional uses, such as in hair restoration and cellulite reduction, broaden market potential. Strategic partnerships, investment in research and development, and the introduction of innovative mesotherapy solutions are crucial to capitalizing on emerging opportunities and sustaining market leadership in the dynamic mesotherapy landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the mesotherapy market globally?
• Which mesotherapy applications and treatment types are driving adoption across different healthcare settings?
• How are technological advancements influencing the competitive landscape of the mesotherapy market?
• Who are the key players contributing to the mesotherapy market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global mesotherapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global mesotherapy market, including Allergan plc, Galderma S.A., and Revance Therapeutics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced mesotherapy solutions, including new injectables, needle-free systems, and combination therapies, catering to diverse patient needs and clinical requirements. Collaborations with cosmetic clinics, dermatologists, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving mesotherapy landscape.

Key Companies Profiled:

• Laboratories FILORGO SA
• INSTITUTE BCN
• mesoskinline
• Koru Pharmaceuticals Co., Ltd.
• Fusion Meso
• TOSKANI COSMETICS
• Dr. Korman Laboratories Ltd.
• Ostar Beauty Sci-Tech Co Ltd.
• Aemesso U.S.A. Corp
• Perse Belle
• Dermo Aroma
• Pluryal
• Messoessence
• Novaderm
• Dermaqual
• Allergan
• Maypharm
• Galderma Laboratories

Key Segments Covered in Mesotherapy Industry Research

Product:

• Mesotherapy Fillers Kits
• Mesotherapy Solutions Kits
• Mesotherapy Chemical Peels
• Anti-ageing Masks
• Mesotherapy Creams
• Mesotherapy Spray

Indication:

• Anti-ageing
• Facial Rejuvenation
• Wrinkle Treatment
• Stretch marks
• Acne & Scar Treatment
• Fat Loss
• Hair Loss/Alopecia

Distribution Channel:

• Hospitals
• Dermatology Clinics
• Cosmetic Clinics
• Online Sales

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Adoption Rate/Usage Analysis - Key Statistics
• 4.2. Value Chain Analysis
• 4.3. Key Regulations - By Region
• 4.4. Product USP Analysis
• 4.5. Recent Product Approvals
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Dermatology Market Outlook
• 5.2. Forecast Factors - Relevance and Impact
  • 5.2.1. Increasing Prevalence of Skin Disease
  • 5.2.2. Rising Prevalence of Skincare
  • 5.2.3. Increased Mergers and Acquisitions
  • 5.2.4. Innovation and Development
  • 5.2.5. New Advancements in Treatment
  • 5.2.6. Regulatory Approvals
  • 5.2.7. Research and Development for New Drugs
  • 5.2.8. Technological Advancements
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Indication
  • 6.1.3. By Distribution Channel
  • 6.1.4. By Region
• 6.2. 2023 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume (Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
  • 10.3.1. Mesotherapy Fillers Kits
  • 10.3.2. Mesotherapy Solutions Kits
  • 10.3.3. Mesotherapy Chemical Peels
  • 10.3.4. Anti-ageing Masks
  • 10.3.5. Mesotherapy Creams
  • 10.3.6. Mesotherapy Spray
    • 10.3.6.1. Mesotherapy Devices
    • 10.3.6.2. Microneedling Pens
    • 10.3.6.3. Dermarollers
    • 10.3.6.4. Injection Guns
    • 10.3.6.5. Mesotherapy Needles and Cannulas
    • 10.3.6.6. Skin Analyzers
• 10.4. Market Attractiveness Analysis, By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024-2033
  • 11.3.1. Anti-ageing
  • 11.3.2. Facial Rejuvenation
  • 11.3.3. Wrinkle Treatment
  • 11.3.4. Stretch marks
  • 11.3.5. Acne and Scar Treatment
  • 11.3.6. Fat Loss
  • 11.3.7. Hair Loss/Alopecia
  • 11.3.8. Others
• 11.4. Market Attractiveness Analysis, By Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 12.3.1. Hospitals
  • 12.3.2. Dermatology Clinics
  • 12.3.3. Cosmetic Clinics
  • 12.3.4. Online Sales
  • 12.3.5. Others
• 12.4. Market Attractiveness Analysis, By Distribution Channel

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2019-2023
• 13.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By Distribution Channel
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis and Forecast
  • 14.8.1. U.S. Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Indication
      • 14.8.1.2.3. By Distribution Channel
  • 14.8.2. Canada Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Indication
      • 14.8.2.2.3. By Distribution Channel

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Indication
  • 15.4.4. By Distribution Channel
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis and Forecast
  • 15.8.1. Mexico Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Indication
      • 15.8.1.2.3. By Distribution Channel
  • 15.8.2. Brazil Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Indication
      • 15.8.2.2.3. By Distribution Channel
  • 15.8.3. Argentina Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Indication
      • 15.8.3.2.3. By Distribution Channel

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Russia
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By Distribution Channel
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis and Forecast
  • 16.8.1. Germany Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Indication
      • 16.8.1.2.3. By Distribution Channel
  • 16.8.2. Italy Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Indication
      • 16.8.2.2.3. By Distribution Channel
  • 16.8.3. France Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Indication
      • 16.8.3.2.3. By Distribution Channel
  • 16.8.4. U.K. Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Indication
      • 16.8.4.2.3. By Distribution Channel
  • 16.8.5. Spain Market Analysis
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Indication
      • 16.8.5.2.3. By Distribution Channel
  • 16.8.6. BENELUX Market Analysis
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Indication
      • 16.8.6.2.3. By Distribution Channel
  • 16.8.7. Russia Market Analysis
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Indication
      • 16.8.7.2.3. By Distribution Channel

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Product
  • 17.4.2. By Indication
  • 17.4.3. By Distribution Channel
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis and Forecast
  • 17.8.1. China Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Indication
      • 17.8.1.2.3. By Distribution Channel
  • 17.8.2. Japan Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Indication
      • 17.8.2.2.3. By Distribution Channel
  • 17.8.3. South Korea Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Indication
      • 17.8.3.2.3. By Distribution Channel

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. India
    • 18.3.1.2. Indonesia
    • 18.3.1.3. Malaysia
    • 18.3.1.4. Thailand
    • 18.3.1.5. Rest of South Asia
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Indication
  • 18.4.4. By Distribution Channel
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis and Forecast
  • 18.8.1. India Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Indication
      • 18.8.1.2.3. By Distribution Channel
  • 18.8.2. Indonesia Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Indication
      • 18.8.2.2.3. By Distribution Channel
  • 18.8.3. Malaysia Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Indication
      • 18.8.3.2.3. By Distribution Channel
  • 18.8.4. Thailand Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Indication
      • 18.8.4.2.3. By Distribution Channel

19. Oceania Market 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Indication
  • 19.3.4. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Indication
  • 19.4.4. By Distribution Channel
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis and Forecast
  • 19.8.1. Australia Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Indication
      • 19.8.1.2.3. By Distribution Channel
  • 19.8.2. New Zealand Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Indication
      • 19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkiye
    • 20.3.1.3. South Africa
    • 20.3.1.4. North Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Indication
  • 20.3.4. By Distribution Channel
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Product
  • 20.4.2. By Indication
  • 20.4.3. By Distribution Channel
• 20.5. Market Trends
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis
• 20.8. Country Level Analysis and Forecast
  • 20.8.1. GCC Countries Market Analysis
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Indication
      • 20.8.1.2.3. By Distribution Channel
  • 20.8.2. Turkiye Market Analysis
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Indication
      • 20.8.2.2.3. By Distribution Channel
  • 20.8.3. South Africa Market Analysis
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Indication
      • 20.8.3.2.3. By Distribution Channel
  • 20.8.4. North Africa Market Analysis
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By Indication
      • 20.8.4.2.3. By Distribution Channel

21. Market Structure Analysis

• 21.1. Market Analysis, by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Concentration
• 21.4. Market Presence Analysis
  • 21.4.1. By Regional Footprints of Players
  • 21.4.2. By Product Footprints of Players
  • 21.4.3. By Channel Footprints of Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Deep Dive
  • 22.2.1. Laboratoires FILORGA SA
    • 22.2.1.1. Overview
    • 22.2.1.2. Product Portfolio
    • 22.2.1.3. Sales Footprint
    • 22.2.1.4. Key Financials
    • 22.2.1.5. SWOT Analysis
    • 22.2.1.6. Strategy Overview
      • 22.2.1.6.1. Marketing Strategy
      • 22.2.1.6.2. Product Strategy
      • 22.2.1.6.3. Channel Strategy
  • 22.2.2. INSTITUTE BCN
    • 22.2.2.1. Overview
    • 22.2.2.2. Product Portfolio
    • 22.2.2.3. Sales Footprint
    • 22.2.2.4. Key Financials
    • 22.2.2.5. SWOT Analysis
    • 22.2.2.6. Strategy Overview
      • 22.2.2.6.1. Marketing Strategy
      • 22.2.2.6.2. Product Strategy
      • 22.2.2.6.3. Channel Strategy
  • 22.2.3. Mesoskinline
    • 22.2.3.1. Overview
    • 22.2.3.2. Product Portfolio
    • 22.2.3.3. Sales Footprint
    • 22.2.3.4. Key Financials
    • 22.2.3.5. SWOT Analysis
    • 22.2.3.6. Strategy Overview
      • 22.2.3.6.1. Marketing Strategy
      • 22.2.3.6.2. Product Strategy
      • 22.2.3.6.3. Channel Strategy
  • 22.2.4. Koru Pharmaceuticals Co., Ltd.
    • 22.2.4.1. Overview
    • 22.2.4.2. Product Portfolio
    • 22.2.4.3. Sales Footprint
    • 22.2.4.4. Key Financials
    • 22.2.4.5. SWOT Analysis
    • 22.2.4.6. Strategy Overview
      • 22.2.4.6.1. Marketing Strategy
      • 22.2.4.6.2. Product Strategy
      • 22.2.4.6.3. Channel Strategy
  • 22.2.5. Fusion Meso
    • 22.2.5.1. Overview
    • 22.2.5.2. Product Portfolio
    • 22.2.5.3. Sales Footprint
    • 22.2.5.4. Key Financials
    • 22.2.5.5. SWOT Analysis
    • 22.2.5.6. Strategy Overview
      • 22.2.5.6.1. Marketing Strategy
      • 22.2.5.6.2. Product Strategy
      • 22.2.5.6.3. Channel Strategy
  • 22.2.6. TOSKANI COSMETICS
    • 22.2.6.1. Overview
    • 22.2.6.2. Product Portfolio
    • 22.2.6.3. Sales Footprint
    • 22.2.6.4. Key Financials
    • 22.2.6.5. SWOT Analysis
    • 22.2.6.6. Strategy Overview
      • 22.2.6.6.1. Marketing Strategy
      • 22.2.6.6.2. Product Strategy
      • 22.2.6.6.3. Channel Strategy
  • 22.2.7. Dr. Korman Laboratories Ltd.
    • 22.2.7.1. Overview
    • 22.2.7.2. Product Portfolio
    • 22.2.7.3. Sales Footprint
    • 22.2.7.4. Key Financials
    • 22.2.7.5. SWOT Analysis
    • 22.2.7.6. Strategy Overview
      • 22.2.7.6.1. Marketing Strategy
      • 22.2.7.6.2. Product Strategy
      • 22.2.7.6.3. Channel Strategy
  • 22.2.8. Ostar Beauty Sci-Tech Co Ltd.
    • 22.2.8.1. Overview
    • 22.2.8.2. Product Portfolio
    • 22.2.8.3. Sales Footprint
    • 22.2.8.4. Key Financials
    • 22.2.8.5. SWOT Analysis
    • 22.2.8.6. Strategy Overview
      • 22.2.8.6.1. Marketing Strategy
      • 22.2.8.6.2. Product Strategy
      • 22.2.8.6.3. Channel Strategy
  • 22.2.9. Aemesso U.S.A. Corp
    • 22.2.9.1. Overview
    • 22.2.9.2. Product Portfolio
    • 22.2.9.3. Sales Footprint
    • 22.2.9.4. Key Financials
    • 22.2.9.5. SWOT Analysis
    • 22.2.9.6. Strategy Overview
      • 22.2.9.6.1. Marketing Strategy
      • 22.2.9.6.2. Product Strategy
      • 22.2.9.6.3. Channel Strategy
  • 22.2.10. Perse Belle
    • 22.2.10.1. Overview
    • 22.2.10.2. Product Portfolio
    • 22.2.10.3. Sales Footprint
    • 22.2.10.4. Key Financials
    • 22.2.10.5. SWOT Analysis
    • 22.2.10.6. Strategy Overview
      • 22.2.10.6.1. Marketing Strategy
      • 22.2.10.6.2. Product Strategy
      • 22.2.10.6.3. Channel Strategy
  • 22.2.11. Dermo Aroma
    • 22.2.11.1. Overview
    • 22.2.11.2. Product Portfolio
    • 22.2.11.3. Sales Footprint
    • 22.2.11.4. Key Financials
    • 22.2.11.5. SWOT Analysis
    • 22.2.11.6. Strategy Overview
      • 22.2.11.6.1. Marketing Strategy
      • 22.2.11.6.2. Product Strategy
      • 22.2.11.6.3. Channel Strategy
  • 22.2.12. Pluryal
    • 22.2.12.1. Overview
    • 22.2.12.2. Product Portfolio
    • 22.2.12.3. Sales Footprint
    • 22.2.12.4. Key Financials
    • 22.2.12.5. SWOT Analysis
    • 22.2.12.6. Strategy Overview
      • 22.2.12.6.1. Marketing Strategy
      • 22.2.12.6.2. Product Strategy
      • 22.2.12.6.3. Channel Strategy
  • 22.2.13. Messoessence
    • 22.2.13.1. Overview
    • 22.2.13.2. Product Portfolio
    • 22.2.13.3. Sales Footprint
    • 22.2.13.4. Key Financials
    • 22.2.13.5. SWOT Analysis
    • 22.2.13.6. Strategy Overview
      • 22.2.13.6.1. Marketing Strategy
      • 22.2.13.6.2. Product Strategy
      • 22.2.13.6.3. Channel Strategy
  • 22.2.14. Novaderm
    • 22.2.14.1. Overview
    • 22.2.14.2. Product Portfolio
    • 22.2.14.3. Sales Footprint
    • 22.2.14.4. Key Financials
    • 22.2.14.5. SWOT Analysis
    • 22.2.14.6. Strategy Overview
      • 22.2.14.6.1. Marketing Strategy
      • 22.2.14.6.2. Product Strategy
      • 22.2.14.6.3. Channel Strategy
  • 22.2.15. Dermaqual
    • 22.2.15.1. Overview
    • 22.2.15.2. Product Portfolio
    • 22.2.15.3. Sales Footprint
    • 22.2.15.4. Key Financials
    • 22.2.15.5. SWOT Analysis
    • 22.2.15.6. Strategy Overview
      • 22.2.15.6.1. Marketing Strategy
      • 22.2.15.6.2. Product Strategy
      • 22.2.15.6.3. Channel Strategy
  • 22.2.16. Allergan
    • 22.2.16.1. Overview
    • 22.2.16.2. Product Portfolio
    • 22.2.16.3. Sales Footprint
    • 22.2.16.4. Key Financials
    • 22.2.16.5. SWOT Analysis
    • 22.2.16.6. Strategy Overview
      • 22.2.16.6.1. Marketing Strategy
      • 22.2.16.6.2. Product Strategy
      • 22.2.16.6.3. Channel Strategy
  • 22.2.17. Maypharm
    • 22.2.17.1. Overview
    • 22.2.17.2. Product Portfolio
    • 22.2.17.3. Sales Footprint
    • 22.2.17.4. Key Financials
    • 22.2.17.5. SWOT Analysis
    • 22.2.17.6. Strategy Overview
      • 22.2.17.6.1. Marketing Strategy
      • 22.2.17.6.2. Product Strategy
      • 22.2.17.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료